Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Abionyx Pharma End-June Cash Position At 8.8 Million Euros

July 23 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * GROSS CASH POSITION FOR FIRST SEMESTER OF 2020
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 8.8 MILLION AT
JUNE
30TH, 2020
    * COMPANY DID NOT GENERATE ANY REVENUE IN FIRST SEMESTER OF
2020
    * GIVEN COVID-19 IMPACT ON HEALTHCARE SYSTEMS, COMPANY IS
STILL
AWAITING CLINICAL DATA THAT MAY INFLUENCE DETERMINATION OF NEW
STRATEGIC PLAN

Source text for Eikon:  ID:nNDL4MNDT9 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Abionyx Pharma SA

See all news